NICE, France, May 27, 2016 -- ERI Scientific Beta, the smart beta index provider offshoot of EDHEC Risk Institute today announced a revolutionary "pay for what you get" approach to index pricing that will disrupt the traditional model of fixed fees on assets under management and enable investors to relate their fees directly to smart beta index performance.
As a non-profit academic institution, ERI Scientific Beta has always sought to provide the best research with favourable conditions to allow investors to invest in the best conditions possible. That is how ERI Scientific Beta made EDHEC Risk Institute's foundational pledge of transparency a reality. This transparency enabled the risks and robustness of strategies whose performance is essentially made up of simulated track records to be challenged. As such, all the data on ERI Scientific Beta's flagship Scientific Beta Multi-Beta Multi-Strategy indices, with the notable inclusion of historical composition, has been made available to investors without restriction. The new pricing proposition is part of ERI Scientific Beta's investor-friendly approach which has enabled it to attract more than USD 10bn in assets under replication for its smart beta indices in three years.
ERI Scientific Beta is offering this new pricing as an alternative to the traditional fixed fees on assets under management (AUM) of smart beta providers, whether asset managers or index providers. It involves a pure performance fees mandate that can be implemented at the request of an investor who only wishes to pay fees if the index has actually outperformed the reference cap-weighted index.
In practical terms, investors who choose this option from June 1, 2016, will pay zero fixed fees and will only pay variable fees if the flagship Scientific Beta Multi-Beta Multi-Strategy index outperforms the reference cap-weighted index.
This offer, with no fixed fees paid upfront and with the provider's remuneration being based on what the provider actually delivers to the investor, is the only one of its kind in the world.
Commenting on this new model, Noël Amenc, CEO of ERI Scientific Beta, said, "Our rationale for this mandate offer is that smart beta providers' claims on the quality and robustness of their strategies should materialise in their live performance. ERI Scientific Beta's initiative is intended to provide consistency between the smart beta provider's revenues and the quality of its offering. It is also testimony to the confidence we have in the performance of our smart beta indices, and notably our flagship Scientific Beta Multi-Beta Multi-Strategy indices, which have outperformed their cap-weighted equivalent by 4.51% on average since their live date."
As part of its policy of transferring know-how to the industry, EDHEC-Risk Institute has set up ERI Scientific Beta. ERI Scientific Beta is an original initiative which aims to favour the adoption of the latest advances in smart beta design and implementation by the whole investment industry. Its academic origin provides the foundation for its strategy: offer, in the best economic conditions possible, the smart beta solutions that are most proven scientifically with full transparency of both the methods and the associated risks.
ERI Scientific Beta, 1 George Street, #07-02, Singapore 049145. For further information, please contact: Séverine Cibelly, Tel.: +33 493 187 863, E-mail: [email protected], Web: www.scientificbeta.com.
Press_release_Pay_for_what_you_get.pdf http://hugin.info/157174/R/2016096/747686.pdf
HUG#2016096


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Instagram Outage Disrupts Thousands of U.S. Users
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



